Skip to main content

Amundi

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1330387 Paris, I0

Position in APLS

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$0
+$0 QoQ
Shares Held
30,721
0.0% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Amundi holds $2,427,056,148 across 70 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 30,721
2025-12-31 30,721
2025-09-30 1,493,678
2025-06-30 1,604,105
2025-03-31 329,582
2024-12-31 329,582
2024-09-30 2,978
2024-03-31 248,483
2023-12-31 241,371
2023-09-30 278,964
2023-06-30 36,104
2023-03-31 36,873
2022-12-31 25,838
2022-09-30 30,408
2022-06-30 3,923
2022-03-31 3,923
2021-12-31 3,923
2021-09-30 3,923
2021-06-30 3,923